| 10:00 12:00 Transplant/HF: 50 Years of Transplantation, What are Best Practices? | |
|---|---|
| 10:00 10:20 | Management of the Sensitized Pre- and Post-Transplant Patient |
| 10:20 10:40 | Surveillance Biopsies do we still need them? |
| 10:40 11:00 | Management of Coronary Artery Vasculopathy State of the Art |
| 11:00 11:20 | Listing for Re-Transplantation: Indications and Outcomes |
| 11:20 11:40 | When a Heart Transplant isnt enough . when are a Kidney or Liver Needed? |
| 11:40 12:00 | Discussion |
| 13:30 15:30 Transplant/HF: Bridging Together: VAD & ICU: Controversies | |
|---|---|
| 13:30 13:50 | VADs in Challenging Patients: Approaching the Tough Cases |
| 13:50 14:10 | Making it Work: VADs in Patients with Univentricular Physiology |
| 14:10 14:30 | Sweating the Details: How to Select the Patient to be Weaned? |
| 14:30 14:50 | Chronic VAD Therapy in Children |
| 14:50 15:10 | Whats Next: The Future of VAD Therapy in Children |
| 15:10 15:30 | Discussion |
| 10:00 12:00 Transplant/HF: Pushing the Limits in Pediatric Heart Transplantation | |
|---|---|
| 10:00 10:20 | Transplant after Cancer and Chemotherapy: How Long do we Have to Wait? |
| 10:20 10:40 | Transplant in Patients with Difficult Anatomy Including Single Lung |
| 10:40 11:00 | Elevated Pulmonary Vascular Resistance what can VADs do for you? |
| 11:00 11:20 | Transplant in Patients with Genetic Syndromes and Autism |
| 11:20 11:40 | How Many Transplants do you get? 3rd, 4th, or More? |
| 11:40 12:00 | Discussion |
| 10:00 12:00 Transplant/HF: The Best of Heart Failure and Transplant Hot Topics and Abstracts | |
|---|---|
| 10:00 11:00 | ABSTRACTS (4) |
| 11:00 11:20 | Pediatric Myocarditis an update |
| 11:20 11:40 | Medical Management of Childhood Hypertrophic Cardiomyopathy |
| 11:40 12:00 | ABO-Incompatible Transplantation Lessons Learned and Future Directions |
| 13:30 15:30 Transplant/HF: Molecular and Genetic Basis of Heart Failure | |
|---|---|
| 13:30 13:50 | Proteomics of Heart Failure |
| 13:50 14:10 | Pediatric Cardiomyopathy the Importance of Genetic and Metabolic Evaluation |
| 14:10 14:30 | Mitochondria and Heart Failure |
| 14:30 14:50 | Biomarkers in Pediatric Heart Failure When and How to Use Them |
| 14:50 15:10 | Clinical Diagnosis in the Genome Era Challenges and New Horizons |
| 15:10 15:30 | Discussion |